Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology
Reference31 articles.
1. Xu YX, Pindolia KR, Janakiraman N, Noth CJ, Chapman RA, Gautam SC (1997) Curcumin, a compound with anti-inflammatory and antioxidant properties, down-regulates chemokine expression in bone marrow stromal cells. Exp Hematol 25(5):413–422
2. Selvam C, Prabu SL, Jordan BC, Purushothaman Y, Umamaheswari A, Hosseini Zare MS, Thilagavathi R (2019) Molecular mechanisms of curcumin and its analogs in colon cancer prevention and treatment. Life Sci 239:117032
3. Wang L, Wang C, Tao Z, Zhao L, Zhu Z, Wu W, He Y, Chen H, Zheng B, Huang X, Yu Y, Yang L, Liang G, Cui R, Chen T (2019) Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer. J Exp Clin Cancer Res 38(1):460
4. Meiyanto E, Husnaa U, Kastian RF, Putri H, Larasati YA, Khumaira A, Pamungkas DDP, Jenie RI, Kawaichi M, Lestari B, Yokoyama T, Kato JY (2021) The target differences of anti-tumorigenesis potential of curcumin and its analogs against HER-2 positive and triple-negative breast cancer cells. Adv Pharm Bull 11(1):188–196
5. Nirgude S, Mahadeva R, Koroth J, Kumar S, Kumar KSS, Gopalakrishnan V, Karki SSS, Choudhary B (2020) ST09, a novel curcumin derivative, blocks cell migration by inhibiting matrix metalloproteases in breast cancer cells and inhibits tumor progression in EAC mouse tumor models. Molecules 25(19):4499